Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005936 · ClinicalTrials.gov registry record
Collection of Liver Tissue for Virologic Studies
A clinical trial of Virus Disease, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT00005936 is a study of Virus Disease that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00005936, a study of Virus Disease, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine liver tissue to investigate the role of viral infections in fulminant hepatitis, liver failure, and profound bone marrow failure. All patients who are undergoing liver biopsy or liver transplantation may participate in this study. For patients undergoing liver biopsy, a small piece of liver tissue will be taken from the sample collected during the scheduled biopsy. For patients undergoing liver transplantation, a small piece of tissue will be collected from the diseased liver that is to be removed.
Conditions Studied
Study Locations (1)
Maryland
- National Heart, Lung and Blood Institute (NHLBI) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2000-06 |
| Est. Completion | 2002-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005936
The ClinicalTrials.gov registry entry for NCT00005936 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Virus Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00005936 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00005936 about?
NCT00005936 is a clinical study titled "Collection of Liver Tissue for Virologic Studies". This study will examine liver tissue to investigate the role of viral infections in fulminant hepatitis, liver failure, and profound bone marrow failure. All patients who are undergoing liver biopsy or liver transplantation may participate in this study. For patients undergoing liver biopsy, a smal...
What is the current status of trial NCT00005936?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2000-06. Estimated completion is 2002-03.
What conditions does trial NCT00005936 study?
This clinical trial studies the following conditions: Virus Disease.
Who is sponsoring clinical trial NCT00005936?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00005936 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.